The Technical Analyst
Select Language :
Puma Biotechnology Inc [PBYI]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Puma Biotechnology Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

Puma Biotechnology Inc is listed at the  Exchange

-4.66% $5.32

America/New_York / 28 mar 2024 @ 13:33


Puma Biotechnology Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 256.46 mill
EPS: 0.450
P/E: 11.82
Earnings Date: May 01, 2024
SharesOutstanding: 48.21 mill
Avg Daily Volume: 0.626 mill
RATING 2024-03-28
S-
Strong Buy
RATINGS
Rating CashFlow: Strong Sell
Return On Equity: Strong Buy
Return On Asset: Strong Buy
DE: Strong Buy
P/E: Strong Buy
Price To Book: Strong Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE 11.82 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
2.01x
Company: PE 11.82 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$-0.176
(-103.30%) $-5.50
Date: 2024-03-28
Expected Trading Range (DAY)

$ 4.69 - 5.91

( +/- 11.58%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-15 Auerbach Alan H Buy 6 577 Common Stock
2024-03-15 Auerbach Alan H Buy 9 047 Stock Option (Right to Buy)
2024-02-12 Wong Alvin F Buy 43 307 Common Stock
2024-02-12 Wong Alvin F Buy 59 946 Stock Option (Right to Buy)
2024-02-12 Nougues Maximo F Buy 43 307 Common Stock
INSIDER POWER
69.48
Last 99 transactions
Buy: 2 879 886 | Sell: 561 464

Forecast: 15:12 - $5.28

Live Trading Signals (every 1 min)

Forecast 1: 13:42 - $5.31
Forecast 2: 14:32 - $5.28
Forecast 3: 15:12 - $5.28
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $5.32 (-4.66% )
Volume 0.148 mill
Avg. Vol. 0.626 mill
% of Avg. Vol 23.59 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Puma Biotechnology Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Puma Biotechnology Inc

RSI

Intraday RSI14 chart for Puma Biotechnology Inc

Last 10 Buy & Sell Signals For PBYI

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:35sell$5.36N/AActive
Profile picture for
            Puma Biotechnology Inc

PBYI

Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for the use of neratinib in combination with capecitabine for the treatment of adult patients with advanced or metastatic HER2-positive breast cancer; PB272 (neratinib, oral) for HER2 mutation-positive solid tumors. It has a license agreement with Pfizer, Inc.; and sub-license agreement with Specialised Therapeutics Asia Pte Ltd., CANbridge BIOMED Limited, Pint Pharma International SA, Knight Therapeutics, Inc., Pierre Fabre Medicament SAS, and Bixink Therapeutics Co., Ltd. The company was founded in 2010 and is headquartered in Los Angeles, California.

Last 10 Buy Signals

Date Signal @
BILIMar 28 - 13:32CNY11.22
NXSTMar 28 - 13:30$171.93
NTAPMar 28 - 13:29$104.94
XCADUSDMar 28 - 13:291.570
GCTMar 28 - 13:2827.12
KCUSXMar 28 - 13:26$188.42
SNYMar 28 - 13:24$48.97
PTENMar 28 - 13:25$12.08
GALAUSDMar 28 - 13:23$0.0665
GRABMar 28 - 13:24$3.17

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.